Imaging agents for diagnosis of parkinson's disease

Abstract

Generally, the present invention is directed to central nervous system dopamine transporter-imaging agents and methods of use thereof. In certain embodiments, the present invention relates to radiolabeled piperidine derivatives for use as imaging agents in the diagnosis of Parkinson's disease. Another aspect of the present invention relates to piperidine monoamine transporter ligands, comprising a functional group capable of chelating a radionuclide, e.g., technetium, and methods of use thereof.

1 . A compound represented by A: 
       
         
           
           
               
               
           
         
       
       wherein
 X represents O or (H) 2 ; 
 R represents H, alkyl, alkoxyl, alkylamino, aryl, heteroaryl, aralkyl, heteroaralkyl, acyl, alkoxycarbonyl, or alkylaminocarbonyl; 
 R 2  represents H; 
 R 3  represents optionally substituted aryl or heteroaryl; 
 R 4  represents H; 
 R 5  represents independently for each occurrence H, alkyl, alkoxyl, alkylamino, aryl, heteroaryl, aralkyl, heteroaralkyl, acyl, alkoxycarbonyl, or alkylaminocarbonyl; and 
 n is 0, 1, or 2. 
 
     
     
         2 - 164 . (canceled)